Pharma Marketing News
Pharma Marketing News Subscribe Glossary Daily Pharma News Feeds
Pharma Marketing Blog Discussion Forums Audio Podcasts Conference Calendar Reader Surveys Pharma Marketing Vendor Directory

PMN Home | Advertising Information | FAQs | About Us | Contact Us | Privacy Policy
ADVERTISEMENT


Share |

Congress Fiddles While Reimportation Issue Burns
Several drug re-importation bills are currently being considered in Congress

Two Senate bills, the Pharmaceutical Market Access and Drug Safety Act of 2004 (S.2328) and the Safe IMPORT Act of 2004 (S.2493), are likely to meet head-to-head in conference committee. While neither may make it out alive in this session of Congress, the issue of re-importation, however, is not likely to go away.

This article offers a useful comparison of the provisions of these bills and illustrates where the lines on the policy debate are being drawn.

Topic headings:

  • The Senate Contenders
  • Comparing Provisions
  • Pharma's Position
  • Table: Drug Importation Bills in Congress
  • Chart: Pharmaceutical Expenditures as Percent of Total health Expenditure (Canada v.s US)

Read this article now. It's FREE...

Download PDF file

PMN38-02
Issue: Vol. 3, No. 8: September 2004
Word Count: 900

Find other articles in related Topic Areas:

More Content


Search All Pharma Marketing News Pages
Pharma Marketing News Email Addr:  

Contact Information
John Mack
Pharma Marketing Network
215-504-4164


Pharma Marketing News | Subscribe | Discussion Forums | Podcasts | Blog
Daily News Briefs | Surveys | Resources/Links | Glossary | Reports
Pharma Marketing Vendor Directory | Conference Calendar | Pharma Jobs
Advertising Information | FAQs | About Us | Privacy Policy

© 2011. VirSci Corporation. All rights reserved.